To determine whether APN provides atheroprotection against AngII-accelerated atherosclerosis, aortas were prepared from separate cohorts of AdGFP and AdAPN mice (n = 12–16 mice/group) after 4 or 8 weeks of treatment. The gene discussed is AGT; the disease is atherosclerosis.